Invictus Pharmacy, a vertically integrated, nationwide licensed pharmacy platform managed by Invictus Ventures Inc., and Mullan Pharmaceutical Inc., a U.S.-based pharmaceutical company committed to ...

Zoetis Inc. (NYSE: ZTS) today announced that the European Commission (EC) has granted marketing authorization for Poulvac ® Procerta ® HVT-ND, a recombinant vector vaccine for the protection of ...

Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...

TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), ...

Investors are closely watching Vera Therapeutics Inc. VERA as the company awaits the U.S. Food and Drug Administration (FDA) ...

The FDA has approved Tryngolza (olezarsen) to reduce triglycerides and acute pancreatitis risk in adults with severe hypertriglyceridemia (TG ≥500mg/dL).

Celltrion Testing Access Program Expands Availability of Therapeutic Drug Monitoring to Support Patient Transition to ...

HONG KONG, July 6, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today recent submissions of two Investigational New Drug (IND) applications to the U.S. Food and Drug ...

The Trump administration is closing a loophole that drugmakers could use to avoid negotiations when they add active ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

Merck & Co., Inc. (NYSE:MRK) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 25, Merck & Co., Inc.

The bull case for Viking Therapeutics . Viking Therapeutics' leading weight-loss candidate, VK2735, mimics the actions of two ...